Last reviewed · How we verify
Placebo of Reference product — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Reference product (Placebo of Reference product) — FLUIDDA nv. A placebo formulation designed to match the physical and sensory characteristics of a reference product for blinded clinical trial comparison.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Reference product TARGET | Placebo of Reference product | FLUIDDA nv | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Reference product CI watch — RSS
- Placebo of Reference product CI watch — Atom
- Placebo of Reference product CI watch — JSON
- Placebo of Reference product alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Reference product — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-reference-product. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab